Skip to content

Pennsylvania bill seeks clinical research on psychedelics

Valerie A. Canady

Mental Health Weekly January 14, 2022 DOI: 10.1002/mhw.33077 via OpenAlex

Summary

AI-generated from the abstract

In Pennsylvania, a bill was introduced last fall to create a legal foundation for clinical studies of psilocybin or mushrooms. The legislation would provide funding for clinical trials aimed at treating post-traumatic stress disorder (PTSD) in veterans and first responders.

Study at a glance

Characteristics Peer reviewed
Topics Psilocybin
Keywords Legislation Psychiatry Clinical trial Posttraumatic stress
Key finding A Pennsylvania bill would fund clinical trials of psilocybin for PTSD in veterans and first responders.

Abstract

Legislation to establish a foundation for clinical studies of psilocybin or mushrooms had been introduced in Pennsylvania last fall. The bill would fund clinical trials to address post‐traumatic stress disorder (PTSD) in veterans and first responders.

Explore topics

Comments

No comments yet.

Log in to comment